During the past decade, Klinikum Ingolstadt conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 4 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Klinikum Ingolstadt" #1 sponsor was "Abbott Medical Devices" with 7 trials, followed by "Stiftung Institut fuer Herzinfarktforschung" with 2 trials sponsored, "Acandis GmbH" with 1 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored and "Deutsches Herzzentrum Muenchen" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Ingolstadt" #1 collaborator was "Bayer" with 1 trials as a collaborator, "German Research Foundation" with 1 trials as a collaborator, "Heart Center Leipzig - University Hospital" with 1 trials as a collaborator, "Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest" with 1 trials as a collaborator and "Medtronic" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Klinikum Ingolstadt" are "Heart Failure" (3 trials), "Atrial Fibrillation" (2 trials), "Persistent Atrial Fibrillation" (2 trials), "Acute Stroke" (1 trials) and "Arrhythmia" (1 trials). Many other conditions were trialed in "Klinikum Ingolstadt" in a lesser frequency.

Most popular intervention types in "Klinikum Ingolstadt" are "Device" (7 trials), "Drug" (5 trials), "Other" (3 trials), "Procedure" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "A specific electrophysiology mapping protocol is applicable with the GRID catheter." (1 trials), "AF ablation" (1 trials), "Best Medical Treatment" (1 trials) and "Best endovascular treatment or Best surgical treatment" (1 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum Ingolstadt" are 18 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Klinikum Ingolstadt". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Klinikum Ingolstadt, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum Ingolstadt, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 5 trials that are defined as “Not Applicable".

Klinikum Ingolstadt has several departments that took part in Clinical trials: "Kardiologie im Klinikum Ingolstadt" - 3 trials